Trademark: INCRUSE ELLIPTA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
INCRUSE ELLIPTA
Click here to search for trademarks similar to INCRUSE ELLIPTA
Proof of use for INCRUSE ELLIPTA
We do not have any records of a proof of use for INCRUSE ELLIPTA at this moment.
Possible trademark infringements of INCRUSE ELLIPTA
Basic Information about INCRUSE ELLIPTA
- Serial Number
- 86236331
- Filing Date
- 29 Mar 2014
- Registration Number
- 5186819
- Registration Date
- 18 Apr 2017
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of INCRUSE ELLIPTA on the blockchain with WikiTrademarks.io.
- First use of INCRUSE ELLIPTA anywhere
- INCRUSE ELLIPTA was first used on 26 Jan 2015 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns INCRUSE ELLIPTA?
1. Glaxo Group Limited Stevenage
2. Glaxo Group Limited Brentford, Middlesex
3. Glaxo Group Limited Brentford, Middlesex
Correspondent
- Christopher M. Hanes
- GSK
- 410 Blackwell Street
- Legal Brand Protection
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io